analytics_image
Access TOC - Biobanking Market 2025\
Vantage Market Research
Vantage Market Research

Reports - Biobanking Market

iconBiotechnology and Life Sciences

Biobanking Market

Biobanking Market Size, Growth Projections And Insights 2025-2035 by Product and Service (Equipment, Consumables, Services, Software), by Sample Type (Blood Products, Human Tissues, Nucleic Acids, Cell Lines), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Table of Contents

Chapter 1   Executive Dashboard
1. Strategic Imperatives
Chapter 2   Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3   Global Biobanking Market - Segment Analysis
1. Overview
2. Global Biobanking Market, 2021 - 2035 (USD Million)
3. Global Biobanking Market - by Product and Service
3.1. By Equipment
3.2. By Consumables
3.3. By Services
3.4. By Software
4. Global Biobanking Market - by Sample Type
4.1. By Blood Products
4.2. By Human Tissues
4.3. By Nucleic Acids
4.4. By Cell Lines
4.5. By Biological Fluids
4.6. By Human Waste Products
5. Global Biobanking Market - by Application
5.1. By Regenerative Medicine
5.2. By Life Science Research
5.3. By Clinical Research
6. Global Biobanking Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4   North America Biobanking Market - Segment Analysis
1. Overview
2. North America Biobanking Market, 2021 - 2035 (USD Million)
3. North America Biobanking Market - by Product and Service
3.1. By Equipment
3.2. By Consumables
3.3. By Services
3.4. By Software
4. North America Biobanking Market - by Sample Type
4.1. By Blood Products
4.2. By Human Tissues
4.3. By Nucleic Acids
4.4. By Cell Lines
4.5. By Biological Fluids
4.6. By Human Waste Products
5. North America Biobanking Market - by Application
5.1. By Regenerative Medicine
5.2. By Life Science Research
5.3. By Clinical Research
Chapter 5   Europe Biobanking Market - Segment Analysis
1. Overview
2. Europe Biobanking Market, 2021 - 2035 (USD Million)
3. Europe Biobanking Market - by Product and Service
3.1. By Equipment
3.2. By Consumables
3.3. By Services
3.4. By Software
4. Europe Biobanking Market - by Sample Type
4.1. By Blood Products
4.2. By Human Tissues
4.3. By Nucleic Acids
4.4. By Cell Lines
4.5. By Biological Fluids
4.6. By Human Waste Products
5. Europe Biobanking Market - by Application
5.1. By Regenerative Medicine
5.2. By Life Science Research
5.3. By Clinical Research
Chapter 6   Asia Pacific Biobanking Market - Segment Analysis
1. Overview
2. Asia Pacific Biobanking Market, 2021 - 2035 (USD Million)
3. Asia Pacific Biobanking Market - by Product and Service
3.1. By Equipment
3.2. By Consumables
3.3. By Services
3.4. By Software
4. Asia Pacific Biobanking Market - by Sample Type
4.1. By Blood Products
4.2. By Human Tissues
4.3. By Nucleic Acids
4.4. By Cell Lines
4.5. By Biological Fluids
4.6. By Human Waste Products
5. Asia Pacific Biobanking Market - by Application
5.1. By Regenerative Medicine
5.2. By Life Science Research
5.3. By Clinical Research
Chapter 7   Latin America Biobanking Market - Segment Analysis
1. Overview
2. Latin America Biobanking Market, 2021 - 2035 (USD Million)
3. Latin America Biobanking Market - by Product and Service
3.1. By Equipment
3.2. By Consumables
3.3. By Services
3.4. By Software
4. Latin America Biobanking Market - by Sample Type
4.1. By Blood Products
4.2. By Human Tissues
4.3. By Nucleic Acids
4.4. By Cell Lines
4.5. By Biological Fluids
4.6. By Human Waste Products
5. Latin America Biobanking Market - by Application
5.1. By Regenerative Medicine
5.2. By Life Science Research
5.3. By Clinical Research
Chapter 8   Middle East & Africa Biobanking Market - Segment Analysis
1. Overview
2. Middle East & Africa Biobanking Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Biobanking Market - by Product and Service
3.1. By Equipment
3.2. By Consumables
3.3. By Services
3.4. By Software
4. Middle East & Africa Biobanking Market - by Sample Type
4.1. By Blood Products
4.2. By Human Tissues
4.3. By Nucleic Acids
4.4. By Cell Lines
4.5. By Biological Fluids
4.6. By Human Waste Products
5. Middle East & Africa Biobanking Market - by Application
5.1. By Regenerative Medicine
5.2. By Life Science Research
5.3. By Clinical Research
Chapter 9   Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10   COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11   Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12   Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13   Company Profiles
1. Thermo Fisher Scientific Inc. (U.S.)
2. Tecan Group Ltd. (Switzerland)
3. Qiagen N.V. (Germany)
4. Hamilton Company (U.S.)
5. Brooks Automation (U.S.)
6. TTP Labtech Ltd (U.K.)
7. VWR Corporation (U.S.)
8. Promega Corporation (U.S.)
9. Worthington Industries (Taylor Wharton - U.S.)
10. Chart Industries (U.S.)
11. Becton
12. Dickinson and Company (U.S.)
13. Merck KGaA (Germany)
14. Micronic (Netherlands)
15. LVL Technologies GmbH & Co. KG (Germany)
16. Panasonic Healthcare Holdings Co. Ltd (Japan)
17. Greiner Bio One (Greiner Holding AG - Austria)
18. Biokryo GmbH (Germany)
19. Biobank AS (Norway)
20. Biorep Technologies Inc. (U.S.)
21. Cell & Co Bioservices (France)
22. RUCDR infinite biologics (U.S.)
23. Modul-Bio (France)
24. CSols Ltd (U.K.)
25. Ziath (U.K.)
26. LabVantage Solutions Inc. (U.S.)
Chapter 14   Key Primary Respondents - VERBATIM
Chapter 15   Discussion Guide
Chapter 16   Customization Offered
Chapter 17   Annexure
Chapter 18   List of Figures
Chapter 19   List of Tables
Chapter 20   List of Abbreviations

FAQ‘s

Related Reports

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by